Ranjan Brijesh, Kumar Randhir, Verma Neeraj, Mittal Swati, Pakrasi Pranab Lal, Kumar R Venkatesh
Department of Applied Animal Sciences, Sericulture Laboratory, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India.
Department of Zoology, Embryo Physiology Laboratory, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Pharmacogn Mag. 2017 Jul;13(Suppl 2):S280-S288. doi: 10.4103/pm.pm_490_16. Epub 2017 Jul 11.
Diabetes is a metabolic disease prevalent worldwide in all age group of people. The source of diabetes is due to an oxidation process that can produce free radicals. An increase in oxidative free radicals in the body is reported to be one of the several causes of diabetes. The best remedy to combat oxidative stress is the use of antioxidants, which inhibit and scavenge free radicals.
This study has been undertaken to evaluate the antioxidant activity and antidiabetic effect of mulberry leaf extract in diabetic mice.
Antioxidant activity of mulberry leaves was determined by 2,2-diphenyl-1-picryl-hydrazyl (DPPH) and ferric reducing/antioxidant power (FRAP) assay. Antidiabetic assay of mulberry leaf extract was analyzed by oral administration of leaf extract up to 3 weeks in diabetic mice induced by streptozotocin.
antioxidant activity in both DPPH and FRAP assays showed significantly ( < 0.05) higher inhibition of free radicals than that with ascorbic acid. Diabetic mice fed with mulberry leaf extract showed increment (+25.88%) in body weight and a significant reduction in blood glucose concentration (-71.58%). Further, glucose-6-phosphate dehydrogenase enzyme activity was significantly ( < 0.05) increased, whereas activities of other enzymes particularly catalase, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase were decreased in diabetic mice after oral administration of mulberry leaf extracts. Histology of liver revealed regeneration of hepatocytes, central vein, and nucleus.
This study demonstrated that S-1708 mulberry variety has a potential therapeutic value in diabetes and related complications.
Diabetes mellitus is a grave metabolic deviations and responsible for many complications affecting various organs in the human body. In spite of the known antidiabetic medicine available in the market, diabetes and the associated impediments sustained to be a major medical crisis. Medicinal plants have been proven to be useful in diabetes due to their rich therapeutic value. In the current study, S-1708 mulberry variety not only authenticated the earlier results obtained from other medicinal plants but also turn out to be known as a potential source for treating diabetes by demonstrating tremendous ant- diabetic properties. S-1708, DPPH, FRAP.
糖尿病是一种在全球所有年龄段人群中普遍存在的代谢性疾病。糖尿病的根源在于一种能产生自由基的氧化过程。据报道,体内氧化自由基的增加是糖尿病的多种病因之一。对抗氧化应激的最佳方法是使用抗氧化剂,其可抑制和清除自由基。
本研究旨在评估桑叶提取物对糖尿病小鼠的抗氧化活性和抗糖尿病作用。
通过2,2-二苯基-1-苦基肼(DPPH)和铁还原/抗氧化能力(FRAP)测定法测定桑叶的抗氧化活性。通过对链脲佐菌素诱导的糖尿病小鼠口服叶提取物长达3周来分析桑叶提取物的抗糖尿病测定。
DPPH和FRAP测定中的抗氧化活性均显示出比抗坏血酸对自由基的抑制作用显著更高(<0.05)。喂食桑叶提取物的糖尿病小鼠体重增加(+25.88%),血糖浓度显著降低(-71.58%)。此外,口服桑叶提取物后,糖尿病小鼠体内的葡萄糖-6-磷酸脱氢酶活性显著(<0.05)升高,而其他酶特别是过氧化氢酶、血清谷氨酸草酰乙酸转氨酶、血清谷氨酸丙酮酸转氨酶的活性降低。肝脏组织学显示肝细胞、中央静脉和细胞核的再生。
本研究表明S-1708桑品种在糖尿病及相关并发症方面具有潜在的治疗价值。
糖尿病是一种严重的代谢紊乱,会引发许多影响人体各个器官的并发症。尽管市场上有已知的抗糖尿病药物,但糖尿病及其相关障碍仍然是一个重大的医疗危机。药用植物因其丰富的治疗价值已被证明对糖尿病有用。在当前研究中,S-1708桑品种不仅证实了从其他药用植物获得的早期结果,而且通过展示出巨大的抗糖尿病特性,成为治疗糖尿病的潜在来源。S-1708、DPPH、FRAP。